Authors
Latest:
Electronic Health Risk Assessment Adoption in an Integrated Healthcare SystemSignificant additional outreach and engagement strategies and incentives are likely required to increase adoption and ongoing use of health risk assessment tools among target populations.
Latest:
Adalimumab Persistence for Inflammatory Bowel Disease in Veteran and Insured CohortsVeterans with inflammatory bowel disease taking adalimumab appear to be more likely to remain on the drug 1 year after initiation than patients who are privately insured.
Latest:
Comparative Effectiveness and Costs of Insulin Pump Therapy for DiabetesEvaluation of healthcare utilization and costs over 3 years for adults with insulin-requiring diabetes who transition from multiple daily insulin injections to insulin infusion pumps.
Latest:
Drug Adherence After Price Changes in a Previously Compliant PopulationThe impact of price changes in drugs, at least among previously adherent patients, was modest in size except for drugs with large price changes.
Latest:
Payer—Provider Patient Registry Utilized in a Behavioral Health HomeA payer—provider, patient registry to identify individuals with serious mental illness and chronic physical health conditions for utilization in behavioral health homes is described.
Latest:
Dental Care Coverage TransitionsThis study examines dental insurance transition dynamics in the context of changing employment and retirement status.
Latest:
Predictive Model for Emergency Hospital Admission and 6-Month ReadmissionPredictive models for hospital admissions and readmissions in persons aged >65 years have been developed through a combination of comorbidity and previous healthcare use.
Latest:
Ezetimibe 5 and 10 mg for Lowering LDL-C: Potential Billion-Dollar Savings With Improved TolerabilityThis retrospective study strongly suggests that splitting a 10-mg ezetimibe tablet yields a 5-mg dose that is clinically equivalent to the 10-mg dose.
Latest:
Systematic Review of Comparative Effectiveness Data for Oncology Orphan DrugsThis study critically assessed the published clinical and economic evidence supporting oncology orphan drugs marketed in the United States.
Latest:
Electronic Health Record Problem Lists: Accurate Enough for Risk Adjustment?Electronic health record (EHR)-based comorbidity assessment had low sensitivity for identifying major comorbidities and poorly predicted survival. EHR-based comorbidity data require validation prior to application to risk adjustment.
Latest:
Effect of Medication Burden on Persistent Use of Lipid-Lowering Drugs Among Patients With HypertensionThis study assesses the effect of medication burden on persistent use of newly added lipid-lowering drugs among patients with hypertension.
Latest:
Adherence to Statins and LDL-Cholesterol Goal AttainmentThis study examined adherence to statins and low-density lipoprotein cholesterol goal attainment in patients with coronary artery disease.
Latest:
Decision Aids for Benign Prostatic Hyperplasia and Prostate CancerImplementing patient decision aids was associated with lower rates of elective surgery for benign prostatic hyperplasia and of active treatment for localized prostate cancer.
Latest:
Differential Impact of Mental Health Multimorbidity on Healthcare Costs in DiabetesAssessment of prevalence and specific costs associated with discrete multimorbid mental health disease clusters in adults with diabetes.
